Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other financing activities (2018 - 2025)

Collegium Pharmaceutical (COLL) has 3 years of Other financing activities data on record, last reported at $964000.0 in Q3 2025.

  • For Q3 2025, Other financing activities rose 578.87% year-over-year to $964000.0; the TTM value through Sep 2025 reached $12.1 million, down 35.81%, while the annual FY2015 figure was -$16000.0, N/A changed from the prior year.
  • Other financing activities reached $964000.0 in Q3 2025 per COLL's latest filing, up from $428000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $12.9 million in Q1 2024 and bottomed at $142000.0 in Q3 2024.